Jack Jinqi Ren, Ph.D., joined StrideBio’s adeno-associated virus manufacturing team in June 2019. Dr. Ren has focused on biomolecule purification and drug discovery for more than 18 years. He previously served as a purification scientist for G-protein-coupled receptors drug screening at KXTbio Inc. Prior to that, he led the monoclonal antibody purification team at Yunda Biotech Ltd. for three years.
Dr. Ren received his Ph.D. from the Chinese Academy of Sciences in Cell Biology, followed by postdoctoral training at the University of Pennsylvania. In 2013, he joined the University of North Carolina at Chapel Hill and coordinated the high-throughput screening of GTPase program with GlaxoSmithKline’s Discovery Partnerships with Academia program.